Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check4 days agoChange DetectedThe study record history page appears unchanged, with its version list and study update categories intact.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA newer site revision (v3.7.0) was added to the history. The older revision (v3.6.6) was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedNew version entries dated 2026-09-10 and 2026-09-11 were added to the study record history, including updates to the Study Status and Contacts/Locations sections. The entry dated 2026-03-04 was removed from the history.SummaryDifference0.3%

- Check39 days agoChange DetectedA new revision entry, v3.6.6, has been added to the record history, and the previous revision entry, v3.6.5, has been removed from the list, indicating an update to the version history of the study record.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays the software revision number as v3.6.5, replacing the previous v3.6.4. This reflects a site software update for the page.SummaryDifference0.1%

- Check75 days agoChange DetectedA new software revision tag (v3.6.4) replaces the previous tag (v3.6.3) in the study record history.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.